test

Brendan Corcoran

@Valence8 Us Lp

Latest period2024 - Q3ReportedManaged Assets$241.102MTotal holdings56
Assets growth rate25.66%Assets growth rate (2-Q avg)12.87%Continuous growth in asset value5 quarters

Portfolio positions

This chart displays the top 10 holdings in Valence8 Us Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 56 positions.

Assets under management

The assets under management (AUM) of Valence8 Us Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 5 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 241.102M in assets, with a quarterly growth rate of 25.66% and a 2-quarter average growth rate of 12.87%. The portfolio is managed by Brendan Corcoran, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ARGXArgenx Se
Recent Activity
New Position
0.22%
$516,602
953 shares@ $542.08 avg price
KROSKeros Therapeutics Inc
Recent Activity
New Position
0.2%
$466,012
8,025 shares@ $58.08 avg price
NVONovo-nordisk A S
Recent Activity
New Position
0.2%
$464,373↑ Call
3,900 shares@ $119.07 avg price
JANXJanux Therapeutics Inc
Recent Activity
New Position
0.2%
$461,433↓ Put
10,157 shares@ $45.44 avg price
NUVLNuvalent Inc
Recent Activity
New Position
0.18%
$420,965
4,115 shares@ $102.31 avg price
SAVACassava Sciences Inc
Recent Activity
New Position
0.18%
$414,963↓ Put
14,100 shares@ $29.43 avg price
APLSApellis Pharmaceuticals Inc
Recent Activity
New Position
0.16%
$377,804↑ Call
13,100 shares@ $28.84 avg price
AVDLAvadel Pharmaceuticals Plc
Recent Activity
New Position
0.15%
$343,613↑ Call
26,200 shares@ $13.12 avg price
CRNXCrinetics Pharmaceuticals In
Recent Activity
New Position
0.15%
$341,552
6,684 shares@ $51.1 avg price
TYRATyra Biosciences Inc
Recent Activity
New Position
0.13%
$310,050
13,188 shares@ $23.52 avg price